The disease is linked to mutations in the VHL gene located on chromosome 3p25-26. This gene produces a protein that helps regulate cell proliferation and angiogenesis. Mutations in the VHL gene lead to uncontrolled cell growth and the formation of tumors. Genetic testing can confirm the presence of VHL mutations, which is critical for early diagnosis and management.
